>> 全站文章索引 >> 第13页:
  • Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial - [Zbigniew Zylicz, Malgorzata Krajnik, Adriaan Alistar van Sorge and Massimo Costantini]
  • Antidepressant-like effects in various mice strains in the tail suspension test - [Nadège Ripoll, Denis Joseph Paul David, Eric Dailly, Martine Hasco?t and Michel Bourin]
  • Effects of Endogenous Neurotransmitters on the in vivo Binding of Dopamine and 5-HT Radiotracers in Mice - [Onarae V Rice1 MA, S John Gatley1 Ph.D, Ji Shen1 Ph.D, Craig L Huemmer1 BS, Renata Rogoz1 Ph.D, Onofre T DeJesus2 Ph.D, Nora D Volkow1 MD and Andrew N Gifford1 Ph.D]
  • Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis - [Vincenzo Pucci 1, Salvatore Fanali 2, Cesare Sabbioni 1, Maria Augusta Raggi * AD:1University of Bologna, Department of Pharmaceutical Sciences, Via Belmeloro 6, 40126 Bologna, Italy; Fax: +39 051 20997342National Council of Research, Institute of Chemist]
  • Local 5,7-Dihydroxytryptamine Lesions of Rat Amygdala: Release of Punished Drinking, Unaffected Plus-Maze Behavior and Ethanol Consumption - [Wolfgang Sommer1 MD, Ph.D, Christian Moller1 MD, Ph.D, Lisa Wiklund1 BSc, Annika Thorsell1 Ph.D, Roberto Rimondini1 Ph.D, Hans Nissbrandt2 MD, Ph.D and Markus Heilig1 MD, Ph.D]
  • Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood - [Endrass J, Vetter S, Gamma A, Gallo WT, Rossegger A, Urbaniok F, Angst J.]
  • Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice - [Florence Clenet, Anouk De Vos and Michel Bourin]
  • The Gerbil Elevated Plus-Maze I: Behavioral Characterization and Pharmacological Validation - [Geoffrey B Varty, Cynthia A Morgan, Mary E Cohen-Williams, Vicki L Coffin, Galen J Carey]
  • Sleep in obsessive compulsive disorder:Polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency - [Voderholzer U, Riemann D, Huwig-Poppe C, Kuelz AK, Kordon A, Bruestle K, Berger M, Hohagen F.]
  • Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia - [Christoforou A, Le Hellard S, Thomson PA, Morris SW, Tenesa A, Pickard BS, Wray NR, Muir WJ, Blackwood DH, Porteous DJ, Evans KL.]
  • Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder - [E. Hernández, S. Lastra, M. Urbina, I. Carreira and L. Lima]
  • Enzymatic alkoxycarbonylation reactions on the intermediate in the synthesis of (?)-paroxetine, trans-N-benzyloxycarbonyl-4-(4′-fluorophenyl)-3-hydroxymethylpiperidine - [Gonzalo de Gonzalo, Rosario Brieva, Víctor M. Sánchez, Miguel Bayod and Vicente Gotor]
  • Decreased Neuroendocrine Responses to Meta-Chlorophenylpiperazine (m-CPP) but Normal Responses to Ipsapirone in Marathon Runners - [Andreas Broocks1 MD, Tim Meyer5 MD, Annette George2 MD, Ursula Hillmer-Vogel4 MD, Detlef Meyer1 MD, Borwin Bandelow1 MD, G?ran Hajak1 MD, Uwe Bartmann1 Ph.D, Christoph H Gleiter3 MD and Eckart Rüther1 MD]
  • Drug sales in four European countries still differ - [Silvio Garattini, Livio Garattini]
  • Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors - [M. H. Nelson, A. K. Birnbaum and R. P. Remmel]
  • Clinical implications of pharmacogenetics of antidepressants - [Koichi Otani, Kazuo Mihara, Norio Yasui-Furukori, Akihito Suzuki, Tsuyoshi Kondo and Sunao Kaneko]
  • Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. - [Richelson E]
  • Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression - [Margareta Reis 1 2 *, Anna ?berg-Wistedt 3, Hans ?gren 4, Peter H?glund 2, Ann-Charlotte ?kerblad 5, Finn Bengtsson 5 AD:1Department of Medicine and Care, Division of Clinical Pharmacology, Faculty of Health Sciences, Link?ping University, Link?ping, Swed]
  • Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel - [Christina I. Petersen, Louis J. DeFelice]
  • 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand - [Shunichi Oya, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton, Michael Siciliano and Hank F. Kung]
  • Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens - [Nemesio Cede?o, Mary Urbina, Francisco Obregón and Lucimey Lima]
  • Decrease of Serotonin Transporters in Blood Platelets after Epileptic Seizures - [Aroldo Cupello, Emilio Favale, Daniela Audenino, Simona Scarrone, Stefania Gastaldi, Claudio Albano]
  • Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Ikuyo Motoki, Sumiko Tayoshi, Koshi Ohta, Hongwei Song, Kyoko Morita, Kazuhito Rokutan and Tetsuro Ohmori]
  • Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene - [Giampaolo Perna1, Elisa Favaron1, Daniela Di Bella1, Riccardo Bussi1 and Laura Bellodi1]
  • Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder - [Mikael Landén1, Hans Nissbrandt2, Christer Allgulander3, Karin S?rvik4, Christina Ysander4 and Elias Eriksson2,4]
  • Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials - [Roja Rahimi, Shekoufeh Nikfar and Mohammad Abdollahi]
  • Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression - [Sanjaya Saxena, Arthur L Brody, Matthew L Ho, Narineh Zohrabi, et al]
  • Antidepressant-induced regulation of 5-HT1b mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation - [J.P. Anthony, T.J. Sexton, J.F. Neumaier * Department of Psychiatry and Behavioral Sciences and Harborview Medical Center, University of Washington, Seattle]
  • The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine - [T Sugai1, Y Suzuki1, K Sawamura1, N Fukui1, Y Inoue2 and T Someya1]
  • Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. - [Ueda N, Yoshimura R, Shinkai K, Sakata Y, Nakamura J]
  • Resource use and costs associated with patients treated for depression in primary care - [Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, M?rtensson B, J?nsson B.]
  • Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine - [Christer Allgulander 1 *, Richard Mangano 2, Jun Zhang 2, Alv A. Dahl 3, Ulla Lepola 4, Ingemar Sj?din 5, Gerard Emilien 6, for the SAD 388 Study Group AD:1Karolinska Institutet, The Neurotec Department, Section of Psychiatry, Stockholm, Sweden2Wyeth Rese]
  • Placental passage of antidepressant medications. - [Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D]
  • Measuring Anxiety in Patients with Schizophrenia - [Seedat S, Fritelli V, Oosthuizen P, Emsley RA, Stein DJ.]
  • Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. - [Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD]
  • Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. - [Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA]
  • Effect of paroxetine on thyroid hormone levels in severely depressed patients. - [Konig F, Hauger B, von Hippel, Wolfersdorf M, Kaschka WP]
  • Animal models in urological disease and sexual dysfunction - [Gordon McMurray1, James H Casey1 and Alasdair M Naylor1]
  • Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature - [Fran?ois Therrien 1, John S. Markowitz 2 * AD:1Faculté de Pharmacie, Université de Montréal, 2900, Boul. Edouard-Montpetit, C.P. 6128, succursale A, Montréal, Québec, Canada, H3C 3J72Department of Pharmacy Practice, Institute of Psychiatry, Medical U]
  • Role of 5-HT1A and 5-HT1B Receptors in the Mediation of Behavior in the Forced Swim Test in Mice - [Michael F O]
  • Anger experience and expression across the anxiety disorders - [Moscovitch DA, McCabe RE, Antony MM, Rocca L, Swinson RP.]
  • The association of insomnia with anxiety disorders and depression-Exploration of the direction of risk - [Johnson EO, Roth T, Breslau N.]
  • Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin - [Thomas J. Connor, Michael C. Dennedy, Andrew Harkin and John P. Kelly]
  • Electrophysiological Evidence for the Tonic Activation of 5-HT1A Autoreceptors in the Rat Dorsal Raphe Nucleus - [Nasser Haddjeri1, Normand Lavoie2 and Pierre Blier2]
  • Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[14C]methyl--tryptophan - [Fumitaka Yamane, Hidehiko Okazawa, Pierre Blier and Mirko Diksic]
  • 1-(m-Chlorophenyl)piperazine (mCPP) Dissociates In Vivo Serotonin Release from Long-Term Serotonin Depletion in Rat Brain - [Michael H Baumann Ph.D, Mario A Ayestas BS, Christina M Dersch MS and Richard B Rothman MD, Ph.D]
  • Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions - [T. A. Slotkin, F. J. Seidler and S. F. Ali]
  • The Kutcher Adolescent Depression Scale: Assessment of Its Evaluative Properties over the Course of an 8-Week Pediatric Pharmacotherapy Trial - [Sarah J. Brooks, Stanley P. Krulewicz, Stan Kutcher]
  • Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms - [David C Mamo, Robert A Sweet, Benoit H Mulsant, Bruce G Pollock, et al.]
  • A twelve-week, double-blind, Randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients - [Benoit H Mulsant, Bruce G Pollock, Robert Nebes, Mark D Miller, et al.]
  • Blockade of 5-HT1A Receptors by ()-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice - [Jean-Philippe Guilloux1, Denis J P David1, Bruno P Guiard1, Franck Chenu2, Christelle Repérant1, Miklos Toth3, Michel Bourin2 and Alain M Gardier1]
  • Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities - [A. B. Biswas 1 *, S. Bhaumik 1, D. Branford 2 AD:1University of Leicester, & Leicestershire and Rutland Healthcare NHS Trust, Frith Hospital, Groby Road, Leicester LE3 9QF, UK2Southern Derbyshire Mental Health Trust, Kingsway Hospital, Derby DE22 3LZ, UK]
  • Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study - [Malcolm Lader, M.D. 1 *, Karina Stender, Ph.D. 2, Vera Bürger, M.Sc. 3, Rico Nil, Ph.D. 4 AD:1Institute of Psychiatry, University of London, London, United Kingdom2H. Lundbeck A/S, Copenhagen, Denmark3Lundbeck Austria GmbH, Vienna, Austria4Lundbeck (Swit]
  • Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [11C] DASB PET imaging study - [Jeffrey H Meyer, Alan A Wilson, Nathalie Ginovart, Verdell Goulding, et al]
  • Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain - [Kazufumi Hirano, Takahiro Seki, Norio Sakai, Yasuhiro Kato, Hisakuni Hashimoto, Shinya Uchida and Shizuo Yamada]
  • Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography - [L. Labat, M. Deveaux, P. Dallet and J. P. Dubost]
  • Paroxetine-induced apoptosis in human osteosarcoma cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation - [Chiang-Ting Chou, Shiping He and Chung-Ren Jan]
  • Paroxetine versus citalopram treatment of pathological crying after brain injury - [Ulrich Muller, Toshiya Murai, Thomas Bauer-Wittmund, D. Yves Von Cramon]
  • Which selective serotonin reuptake inhibitor works best? - [Robert K Schneider, James L Levenson]
  • SSRIs and Ejaculation A Double-Blind, Randomized, Fixed-Dose Study With Paroxetine and Citalopram - [Waldinger MD, Zwinderman AH, Olivier B.]
  • Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats - [Trynke R. de Jong, Liselore J.A.E. Snaphaan, Tommy Pattij, Jan G. Veening, Marcel D. Waldinger, Alexander R. Cools and Berend Olivier]
  • Vardenafil reverses erectile dysfunction induced by paroxetine in rats - [J Angulo, E Bischoff, S Gabancho, P Cuevas, I Sáenz de Tejada]
  • α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice - [Fabienne Massé, Martine Hasco?t and Michel Bourin]
  • Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study - [Murray B. Stein, G. Ron Norton, John R. Walker, Mariette J. Chartier and Roger Graham]
  • Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors - [H. Nordeng, R. Lindemann, K. V. Perminov, . Reikvam1]
  • Once-daily high-dose pindolol for SSRI-refractory depression - [Kenneth N. Sokolski, Janet C. Conney, Brenda J. Brown and Edward M. DeMet]
  • High vs Low Anxiety-Related Behavior Rats: An Animal Model of Extremes in Trait Anxiety - [Rainer Landgraf, Alexandra Wigger]
  • Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate–early gene Arc in rat brain - [R. Tordera, Q. Pei, M. Newson, K. Gray, M. Sprakes and T. Sharp]
  • Response selection in schizophrenia - [Pellizzer G, Stephane M.]
  • Normal Personality Characteristics in Schizophrenia A Review of the Literature Involving the FFM - [Dinzeo TJ, Docherty NM.]
  • Antipsychotics inhibit TREK but not TRAAK channels - [Susanne Thümmler, Fabrice Duprat and Michel Lazdunski]
  • Response styles among patients with minor depression and dysthymia in primary care - [College of Health Sciences, University of Texas at El Paso, 79902, USA. schmaling@utep.edu]
  • A Review of the Bioactivity of South African Herbal Teas Rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia) - [McKay DL, Blumberg JB.]
  • Traitement d'une intoxication à l'hydroxychloroquine par circulation extracorporelle - [F. Mongenot, Y. Tessier Gonthier, F. Derderian, M. Durand and D. Blin]
  • Récepteurs 5-HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonine5-HT1B receptors mediate the antidepressant effects of selective serotonin reuptake inhibitors. - [Alain M. Gardier, Anne-Cécile Trillat, Isabelle Malagié, Denis David, Martine Hasco?t, Marie-Claude Colombel, Pascale Jolliet, Christian Jacquot, René Hen and Michel Bourin]
  • Troubles dysphoriques prémenstruels : diagnostic et traitements médicamenteuxPremenstrual dysphoric disorder: diagnostic and pharmacological treatment - [G. Benjelloun and A. Pelissolo]
  • Expose your clinical thinking - [.]
  • DRUG RESISTANCE IN BRAIN DISEASES AND THE ROLE OF DRUG EFFLUX TRANSPORTERS - [Wolfgang L?scher & Heidrun Potschka about the authors]
  • Decreased platelet [3H]paroxetine binding sites in suicide attempters - [Antonella Armani, Gino Giannaccini, Elena Di Nasso, Antonio Lucacchini and Giovanni B. Cassano]
  • Strategies to Reduce Misdiagnosis of Bipolar Depression - [Bowden CL.]
  • General principles for clinical use of repetitive transcranial magnetic stimulation (rTMS) - [Maertens de Noordhout A.]
  • Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats - [Koichi Isogawa, Minoru Fujiki, Jotaro Akiyoshi, Takashi Tsutsumi, Kensuke Kodama, Hirotaka Matsushita, Yoshihiro Tanaka and Hidenori Kobayashi]
  • Effects of Repeated High-Dose Methamphetamine on Local Cerebral Glucose Utilization in Rats - [Yn-Ho Huang1 Ph.D, Shih-Jen Tsai2,3 MD, Ting-Wen Su1 MSc and Cho-Boon Sim2 MD]
  • Remission and Relapse in the Outpatient Care of Schizophrenia Three-year Results From the Schizophrenia Outpatient Health Outcomes Study - [Haro JM, Novick D, Suarez D, Alonso J, Lépine JP, Ratcliffe M; SOHO Study Group.]
  • THE BALANCING ACT - [.]
  • DEPRESSION, ANTIDEPRESSANTS AND SUICIDALITY: A CRITICAL APPRAISAL - [Julio Licinio & Ma-Li Wong about the authors]
  • Intrafamilial Correspondences on Platelet [3H-]Paroxetine-Binding Indices in Bulimic Probands and their Unaffected First-Degree Relatives - [Howard Steiger1,2,3, Lise Gauvin4, Ridha Joober2,3, Mimi Israel1,2,3, N M K Ng Ying Kin2,3, Kenneth R Bruce1,2,3, Jodie Richardson1,5, Simon N Young2 and Julie Hakim1]
  • Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders - [Gerard J Marek1,*, Linda L Carpenter2, Christopher J McDougle3 and Lawrence H Price2]
  • Behavioral and psychophysiological characteristics of children of parents with social phobia a pilot study - [Campbell MJ, Schmidt LA, Santesso DL, Van Ameringen M, Mancini CL, Oakman JM.]
  • Post exercise hypotension is not mediated by the serotonergic system in borderline hypertensive individuals - [J R MacDonald, J M Rosenfeld, M A Tarnopolsky, C D Hogben, C S Ballantyne and J D MacDougall]
  • Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs - [Rebeca Martínez-Turrillas, Joaquín Del Río and Diana Frechilla]
  • Substitution of the selective serotonin reuptake inhibitors fluoxetine and paroxetine for the discriminative stimulus effects of ethanol in rats - [S. Maurel, Rudy Schreiber, Jean De Vry]
  • smalld-small-Cycloserine and performance under different states of anxiety in healthy volunteers - [Bailey JE, Papadopoulos A, Lingford-Hughes A, Nutt DJ.]
  • Comparison of the effects of venlafaxine, paroxetine and desipramineon the pupillary light reflex in man - [P. Bitsios, E. Szabadi, C. M. Bradshaw]
  • Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex - [Frank P. Bymaster, Wei Zhang, Petra A. Carter, Janice Shaw, Eyassu Chernet, Lee Phebus, David T. Wong, Kenneth W. Perry]
  • ffects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder - [Don R. Cherek, Scott D. Lane, Cynthia J. Pietras, Joel L.]
  • Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder - [Don R. Cherek, Scott D. Lane, Cynthia J. Pietras, Joel L. Steinberg]
  • The selective serotonin reuptake inhibitor paroxetine is effectivein more generalized and in less generalized social anxiety disorder - [Dan J. Stein, Murray B. Stein, Wendy Goodwin, Rajinder Kumar, Brian Hunter]
  • Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers - [Caroline Bell, Sue Wilson, Ann Rich, Jayne Bailey, David Nutt]
  • Symptomatic remission in previously untreated patients with schizophrenia 2-year results from the SOHO study - [Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 [13] 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50